Restenosis after coronary angioplasty.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 10151016)

Published in J Interv Cardiol on September 01, 1993

Authors

H V Anderson1, S J Vignale, C R Benedict, J T Willerson

Author Affiliations

1: University of Texas Health Science Center, Houston 77225.

Articles by these authors

Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81

Carbon isotope discrimination in a plant possessing the C4 dicarboxylic acid pathway. Biochem Biophys Res Commun (1970) 2.82

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61

Thrombolysis in acute myocardial infarction. N Engl J Med (1993) 2.55

Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther (2000) 2.47

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol (1987) 2.27

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation (2000) 2.15

Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med (1991) 2.06

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med (1981) 2.00

Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet (1996) 2.00

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation (1991) 1.96

Ryanodine alteration of the contractile state of rat ventricular myocardium. Comparison with dog, cat, and rabbit ventricular tissues. Circ Res (1980) 1.88

Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. Circulation (1975) 1.87

A new method for radionuclide imaging of acute myocardial infarction in humans. Circulation (1974) 1.85

Local effect of serotonin released during coronary angioplasty. N Engl J Med (1994) 1.81

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol (1989) 1.80

Prospects for cardiovascular research. JAMA (2001) 1.79

Photosynthetic rate of a virescent cotton mutant lacking chloroplast grana. Plant Physiol (1970) 1.75

The carboxylation of phosphoenolpyruvate and pyruvate. I. The active species of "CO2" utilized by phosphoenolpyruvate carboxykinase, carboxytransphosphorylase, and pyruvate carboxylase. J Biol Chem (1968) 1.74

Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg (1996) 1.74

Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol. J Clin Invest (1972) 1.74

High-output cardiac failure in patients with multiple myeloma. N Engl J Med (1988) 1.62

Ryanodine: its alterations of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. J Pharmacol Exp Ther (1979) 1.60

Primary amyloidosis. Clinical, immunochemical and immunoglobulin metabolism. Studies in fifteen patients. Am J Med (1969) 1.60

Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids. Circ Res (1984) 1.55

Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. J Clin Invest (1975) 1.55

Experimental murine amyloid. IV. Amyloidosis and immunoglobulins. J Immunol (1969) 1.48

Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo. J Am Coll Cardiol (1990) 1.45

Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain. Circulation (1994) 1.45

Mycoplasma hyorhinis swine arthritis. II. Morphologic features. Arthritis Rheum (1971) 1.44

Association of cytomegalovirus infection with the postperfusion syndrome. N Engl J Med (1968) 1.42

Enzymic Fractionation of the Stable Carbon Isotopes of Carbon Dioxide by Ribulose-1,5-bisphosphate Carboxylase. Plant Physiol (1979) 1.41

Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation (1998) 1.40

Thrombolytic therapy: a state of the art review. Hosp Pract (Off Ed) (1992) 1.40

Relationship of ischemic heart disease to sudden death. J Forensic Sci (1991) 1.39

Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation (1986) 1.35

Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med (1978) 1.34

Assessment of sympathetic overactivity in tetanus. Br Med J (1977) 1.34

Left ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine positions. Circulation (1980) 1.33

Serum myoglobin level as diagnostic test in patients with acute myocardial infarction. Br Heart J (1977) 1.32

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation (2000) 1.31

Amyloidosis induced in mice by Escherichia coli endotoxin. Science (1968) 1.30

Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis. Am J Physiol (1994) 1.27

Properties of farnesyl pyrophosphate synthetase of pig liver. Arch Biochem Biophys (1965) 1.26

Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation (1998) 1.25

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol (1995) 1.25

Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22

Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. J Clin Invest (1979) 1.22

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest (1989) 1.20

Murine amyloid. II. Transfer of an amyloid-accelerating substance. Arthritis Rheum (1969) 1.19

C-reactive protein: linking inflammation to cardiovascular complications. Circulation (2001) 1.18

The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction. Circulation (1981) 1.18

Suicidal and accidental digoxin ingestion. Report of five cases with serum digoxin level correlations. Circulation (1971) 1.18

Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Circulation (1992) 1.18

A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma. Br J Clin Pharmacol (1977) 1.17

Role of inflammation in coronary plaque disruption. Circulation (1994) 1.17

Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ Res (1975) 1.17

The medical treatment of dissecting aortic aneurysms. N Engl J Med (1972) 1.16

Ryanodine-induced stimulation of net Ca++ uptake by cardiac sarcoplasmic reticulum vesicles. J Pharmacol Exp Ther (1979) 1.14

Relationship between epicardial S-T segment changes and myocardial metabolism during acute coronary insufficiency. Circ Res (1973) 1.14

Myocardial infarct imaging with technetium-99m phosphates. Semin Nucl Med (1977) 1.13

Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy. Circulation (1979) 1.13

Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation (2001) 1.12

Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol (1986) 1.12

Morphologic correlates of technetium-99m stannous pyrophosphate imaging of acute myocardial infarcts in dogs. Circulation (1975) 1.11

Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. Br Heart J (1979) 1.10

Detection of acute right ventricular infarction by right precordial electrocardiography. Am J Cardiol (1982) 1.10

Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation (1989) 1.10

Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med (1972) 1.10

Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. J Clin Invest (1985) 1.10

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation (1992) 1.09

Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection. Ann Intern Med (1970) 1.08

Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs. J Clin Invest (1976) 1.07

cis-Polyisoprene Synthesis in Guayule Plants (Parthenium argentatum Gray) Exposed to Low, Nonfreezing Temperatures. Plant Physiol (1984) 1.07

Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Circ Res (1986) 1.07

Clinical implications of anterior S-T segment depression in patients with acute inferior myocardial infarction. Am J Cardiol (1982) 1.07

The role of coronary artery lesions in ischemic heart disease: insights from recent clinicopathologic, coronary arteriographic, and experimental studies. Hum Pathol (1987) 1.07

Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams. Circulation (1975) 1.07

A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol (1999) 1.07

Dissecting aneurysm of the aorta: aortographic features affecting prognosis. Radiology (1972) 1.07

Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs. Circulation (1976) 1.06

Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Circulation (2000) 1.06

Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect. Circ Res (1981) 1.06

The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. Circ Res (1984) 1.05

Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation (1989) 1.04

Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging. Br Heart J (1981) 1.04

Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation (1984) 1.04

Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res (1990) 1.03

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol (2001) 1.03

Fatty acid accumulation and abnormal lipid deposition in peripheral and border zones of experimental myocardial infarcts. J Nucl Med (1978) 1.03

Acetate and bicarbonate metabolism in photosynthetic bacteria. Plant Physiol (1965) 1.03

Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol (1977) 1.02

Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol (1988) 1.01

Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man. Clin Sci Mol Med (1977) 1.01

The neurogenic vasoconstrictor effect of digitalis on coronary vascular resistance. J Clin Invest (1974) 1.01

The development of isocitric lyase activity in germinating cotton seed. Plant Physiol (1974) 1.00